MARKET OVERVIEW:
Diclofenac, sold under the brand name Voltaren among others, is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammatory diseases such as gout. It is taken by mouth, rectally in a suppository, used by injection, or applied to the skin.
Improvements in pain last for as much as eight hours. It is also available in combination with misoprostol in an effort to decrease stomach problems.
MARKET INSIGHT & GROWTH DRIVERS:
This market is gaining traction due to stricter environmental regulations worldwide, particularly in industries such as power generation, cement production, and metal processing..
USD 842.5 million USD 1.28 Billion at 5.1% Click Here for More Detailed
MARKET DYNAMICS
Rising Prevalence of Chronic Pain Conditions to Fuel Diclofenac API Demand
Global Diclofenac Active Pharmaceutical Ingredients (API) market size was valued at USD 387.5 million in 2022. The market is projected to grow at a CAGR of 4.2% from 2023 to 2029, reaching USD 515.8 million by the end of the forecast period. This steady growth is driven by increasing prevalence of inflammatory conditions and expanding generic drug markets worldwide.
MARKET OPPORTUNITIES
Recent advances in drug delivery systems present significant opportunities for diclofenac API utilization. Patent-protected formulations incorporating diclofenac –including transdermal patches with enhanced bioavailability and extendedrelease oral capsules – command premium pricing and are driving API demand growth in developed markets. These value-added formulations help offset declining margins in conventional tablet markets while expanding therapeutic applications.
COMPANY MISSION
Boron neutron capture therapy (BNCT) is emerging as a promising cancer treatment modality, particularly for difficult-to-treat tumors like glioblastoma. Japan has led clinical adoption with over 200 patients treated since 2020, while China and Europe are ramping up clinical trials. The precision targeting capability of boron-10, when irradiated with low-energy neutrons, minimizes damage to healthy tissues - a significant advantage over conventional radiotherapy. Pharmaceutical companies are investing in boron-containing drug development, with several boron-10 based compounds currently in Phase II/III trials for various oncology indications.
REGIONAL MARKET OUTLOOK
North America
North America, particularly the U.S. and Canada, dominates the **Diclofenac API market** due to high demand for nonsteroidal antiinflammatory drugs (NSAIDs) and well-established pharmaceutical manufacturing infrastructure. The U.S. market alone accounts for over **60% of regional revenue**, driven by the prevalence of chronic pain conditions and osteoarthritis. Stringent **FDA regulations** ensure high-quality API production, with significant emphasis on **purity (above 99.5%)** for injectable formulations. The shift toward **patent expirations and generic drug manufacturing** further fuels demand for cost-effective Diclofenac APIs. However, increasing scrutiny on NSAID-related gastrointestinal risks may impact future growth.
Europe
Europe represents the second-largest market, led by **Germany, France, and the U.K.**, where Diclofenac APIs are widely used in topical and oral formulations. **EU-GMP compliance** mandates strict adherence to purity benchmarks, benefiting suppliers with advanced synthesis capabilities. The market is witnessing a surge in **sustained-release formulations**, particularly for rheumatoid arthritis treatment
COMPETITIVE LANDSCAPE
• Granules India Limited (India)
• Huagang Pharm (China)
• Hebei Jiheng Pharmaceutical (China)
• Zhejiang Kangle Pharmaceutical (China)
• Jingye Group (China)
• Hunan Zhongnan Pharmaceutical (China)
• Elam Pharma Pvt. Ltd. (India)
These companies represent some of the major key players driving innovation and growth in the market, contributing significantly to global supply and competitive dynamics.
DOWNLOAD FREE SAMPLE PDF
About Us
Founded in 2015, 24chemicalresearch is a trusted name in global chemical industry intelligence. We specialize in delivering high-quality market research reports, empowering over 30+ Fortune 500 clients with data-driven insights for strategic growth. Our team of experienced analysts delivers customized, reliable, and timely research backed by a rigorous methodology. From mining regulatory trends to forecasting market opportunities, our reports help companies navigate industry challenges, stay competitive, and grow confidently.
As a one-stop platform for the chemical sector, we offer:
• Deep specialization in chemical market analysis
• Customized reports tailored to your needs
• A robust portal with free samples, consulting, and competitive insights
